Generics News

Fylnetra, a Biosimilar to Neulasta, Gets FDA Approval

Publish Date May 31, 2022

Pirfenidone Tablets Now Available for Idiopathic Pulmonary Fibrosis

Publish Date May 13, 2022

First Generic Version of Symbicort Gets FDA Approval

Publish Date March 16, 2022

First Generic Version of Apokyn Drug Cartridges Gets FDA Approval

Publish Date February 25, 2022

Generic Version of Cystadane Now Available

Publish Date February 15, 2022

First Generic Version of Restasis Gets FDA Approval

Publish Date February 3, 2022

Generic Version of Cuvposa Now Available

Publish Date January 5, 2022

FDA Approves Biosimilar Insulin Product Rezvoglar

Publish Date December 21, 2021

Generic Version of Carbaglu Now Available

Publish Date December 21, 2021

Yusimry, a Humira Biosimilar Product, Gets FDA Approval

Publish Date December 21, 2021

Interchangeable Biosimilars to Lantus Now Available

Publish Date November 16, 2021

FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths

Publish Date October 20, 2021

First Generic Version of Chantix Now Available

Publish Date September 23, 2021

First Generic Version of Clindagel Gets FDA Approval

Publish Date August 24, 2021

Semglee Approved as First Interchangeable Biosimilar Insulin Product

Publish Date July 29, 2021

Generic Version of Feraheme Now Available

Publish Date July 16, 2021

Generic Version of Perforomist Now Available

Publish Date June 23, 2021

Generic Version of Soolantra Cream Now Available

Publish Date June 16, 2021

Isotretinoin Capsules, a Generic Version of Absorica, Now Available

Publish Date April 29, 2021

Generic Version of Foscavir Now Available

Publish Date March 16, 2021